Structural Formula (Gly03 0005 01)
Chemical structure of Glycopyrrolate showing its molecular formula C19H28BrNO3 and molecular weight 398.33.*
Glycopyrrolate Injection, Solution
Product Images NDC 76045-203
17 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 76045-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Gly03 0005 02)
An instructional diagram showing the components and outer packaging of a prefilled syringe of Glycopyrrolate injection solution. Labels point to the outer package, plunger rod, label, syringe barrel, luer lock collar, and syringe tip cap, indicating parts not to be removed.*
Figure 2 (Gly03 0005 03)
An instructional illustration showing hands removing a protective covering from a syringe or injection device, likely demonstrating preparation steps for an injection. The image is simple, black and white line art without text.*
Figure 3 (Gly03 0005 04)
An instructional illustration depicting two hands holding a medication vial and a syringe. The image shows the screw-off cap being removed from the vial by twisting, with an arrow indicating the direction of the twist. This demonstrates vial preparation for drug withdrawal, relevant to Glycopyrrolate injection administration.*
Figure (Gly03 0005 05)
Package Label (PRINCIPAL DISPLAY)
Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL solution for intramuscular or intravenous use. The box contains 24 prefilled single-dose syringes of 1 mL each. The labeler is Fresenius Kabi USA, LLC. The label includes usage instructions and caution not to place the syringe on a sterile field.*
Package Label – Principal Display (Glycopyrrolate 1 mL Blister Pack Label)
Glycopyrrolate 0.2 mg/mL Injection, USP in a 1 mL prefilled single dose syringe. The label states it is preservative-free and intended for intramuscular or intravenous use. It includes storage instructions at 20° to 25°C (68° to 77°F) and cautions not to place the syringe on a sterile field. Labeler is Fresenius Kabi USA, LLC.*
Package Label – Principal Display – Glycopyrrolate 1 mL Syringe Label (Gly03 0005 08)
Label for Glycopyrrolate Injection, USP 0.2 mg/mL in a 1 mL single-dose format for intramuscular or intravenous use. The label includes a dosage scale from 0.5 mL to 1 mL and features Fresenius Kabi as the labeler. The product is marked Rx only and includes a barcode with an RFID tag.*
Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 1 mL Carton Panel)
Label for Glycopyrrolate Injection, USP 0.2 mg/mL by Fresenius Kabi USA, LLC. The label indicates the product is for intramuscular or intravenous use, provided in 24 prefilled 1 mL single-dose syringes. It includes a warning not to place the syringe on a sterile field and to discard unused portions.*
Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 1 mL Blister Pack Label)
Glycopyrrolate 0.2 mg/mL injection label for a 1 mL prefilled single dose syringe. The label states that the solution is preservative-free and intended for intramuscular (IM) or intravenous (IV) use. Storage recommended at 20° to 25°C (68° to 77°F) with instructions to discard unused portions and not to place the syringe on a sterile field. The label includes a barcode, lot number, and expiration date fields, and is from Fresenius Kabi USA, LLC.*
Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 1 mL Syringe Label)
The image shows a label for Glycopyrrolate Injection, USP, 0.2 mg/mL in solution form for injection. It is labeled for use by intramuscular (IM) or intravenous (IV) administration. The label also includes the Fresenius Kabi USA, LLC name as the labeler and a barcode with numerical identification.*
Package Label (PRINCIPAL DISPLAY)
Packaging label for Glycopyrrolate Injection USP, 0.4 mg/2 mL (0.2 mg/mL) in injection solution form. The label indicates 24 prefilled single-dose syringes per package for intramuscular or intravenous use. The product is labeled by Fresenius Kabi USA, LLC, and includes instructions not to place the syringe on a sterile field and to discard unused portions.*
Package Label – Principal Display (Glycopyrrolate 2 mL Blister Pack Label)
Label of Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) prefilled single dose syringe. The label states preservative free, for intramuscular or intravenous use, and gives storage instructions at 20 to 25°C. The labeler is Fresenius Kabi USA, LLC.*
Package Label – Principal Display – Glycopyrrolate 2 mL Syringe Label (Gly03 0005 14)
Label for Glycopyrrolate injection, USP, 0.4 mg per 2 mL vial (0.2 mg/mL), single dose for intramuscular or intravenous use. The label includes a graduated volume scale up to 2 mL and is marked with the Fresenius Kabi USA, LLC logo and barcode.*
Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 2 mL Carton Panel)
Glycopyrrolate Injection USP 0.4 mg/2 mL (0.2 mg/mL) prefilled single dose syringes for intramuscular or intravenous use. Package contains 24 syringes of 2 mL each. Label includes caution against placing syringe on a sterile field and to discard unused portions. Labeler is Fresenius Kabi USA, LLC.*
Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 2 mL Blister Pack Label)
Label for Glycopyrrolate Injection USP 0.4 mg/2 mL (0.2 mg/mL) in a 2 mL prefilled single dose syringe by Fresenius Kabi USA, LLC. The label states it is preservative free for intramuscular or intravenous use and includes storage instructions and a barcode with expiration and lot number fields.*
Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 2 mL Syringe Label)
Label for Glycopyrrolate injection, USP, 0.4 mg per 2 mL (0.2 mg/mL) solution for intramuscular or intravenous use. The label shows dosing increments from 0.5 to 2 mL, indicates single dose use, and includes the labeler name Fresenius Kabi USA, LLC along with a barcode and numeric codes.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
